Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 1/20 | 0.47 |
| ▸ | ABAT | P80404 | 1/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 4/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | LPL | P06858 | 2/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.32 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9986342 | 0.85 | PPARG (0.37) | NOS3NOS1LPLLIPG | |
| SCHEMBL3036815 | 0.84 | ENPP2 (0.39) | F11LOXL2F10NOS3NOS1 | |
| SCHEMBL1129027 | 0.83 | LPL (0.32) | LPLLIPG | |
| SCHEMBL18705952 | 0.83 | LPL (0.32) | LPLLIPG | |
| SCHEMBL54815 | 0.81 | MAPK1 (0.32) | — | |
| SCHEMBL1774449 | 0.81 | LTA4H (0.40) | SMN1; SMN2 | |
| SCHEMBL17315637 | 0.81 | RXRA (0.42) | KDM4E | |
| SCHEMBL3393899 | 0.81 | HRH3 (0.40) | NOS3NOS1NOS2HRH3LPL | |
| SCHEMBL6607206 | 0.81 | PPARG (0.34) | LPLLIPG | |
| SCHEMBL19433226 | 0.80 | CA2 (0.42) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115154422-B | CD44 targeting and ROS response nano micelle pharmaceutical composition, and preparation method and application thereof | 四川大学 | 2023-07-07 | — | — | CN | claimed |
| CN-115154422-A | CD44 targeting and ROS responding nano micelle medicine composition, preparation method and application | 四川大学 | 2022-10-11 | — | — | CN | claimed |
| US-12611617-B2 | Chromatographic columns and separation devices comprising a superficially porous material; and use thereof for supercritical fluid chromatography and other chromatography | WATERS TECHNOLOGIES CORPORATION (US) | 2026-04-28 | — | — | US | disclosed |
| US-20240293799-A1 | CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORPORATION (US) | 2024-09-05 | — | — | US | disclosed |
| US-11992824-B2 | Chromatographic materials | WATERS TECHNOLOGIES CORPORATION | 2024-05-28 | — | — | US | disclosed |
| US-20230312577-A1 | DUAL KINASE-BROMODOMAIN INHIBITORS | MONASH UNIVERSITY (AU) | 2023-10-05 | — | — | US | disclosed |
| CN-115154422-B | CD44 targeting and ROS response nano micelle pharmaceutical composition, and preparation method and application thereof | 四川大学 | 2023-07-07 | — | — | CN | disclosed |
| US-20230173406-A1 | CHROMATOGRAPHIC COLUMNS AND SEPARATION DEVICES COMPRISING A SUPERFICIALLY POROUS MATERIAL; AND USE THEREOF FOR SUPERCRITICAL FLUID CHROMATOGRAPHY AND OTHER CHROMATOGRAPHY | WATERS TECHNOLOGIES CORPORATION (US) | 2023-06-08 | — | — | US | disclosed |
| EP-4165045-A1 | DUAL KINASE-BROMODOMAIN INHIBITORS | Monash University (AU) | 2023-04-19 | — | — | EP | disclosed |
| US-11577179-B2 | Chromatographic columns and separation devices comprising a superficially porous material; and use thereof for supercritical fluid chromatography and other chromatography | WATERS TECHNOLOGIES CORPORATION (US) | 2023-02-14 | — | — | US | disclosed |
| CN-115154422-A | CD44 targeting and ROS responding nano micelle medicine composition, preparation method and application | 四川大学 | 2022-10-11 | — | — | CN | disclosed |
| EP-3936226-A2 | CHROMATOGRAPHIC COLUMNS AND SEPARATION DEVICES COMPRISING A SUPERFICIALLY POROUS MATERIAL; AND USE THEREOF FOR SUPERCRITICAL FLUID CHROMATOGRAPHY AND OTHER CHROMATOGRAPHY | Waters Technologies Corporation (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20210331138-A1 | CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORPORATION (US) | 2021-10-28 | — | — | US | disclosed |
| CN-111205310-A | Heterocyclic fused pyrimidine derivative, and pharmaceutical composition and application thereof | 上海迪诺医药科技有限公司 | 2020-05-29 | — | — | CN | disclosed |
| US-10265679-B2 | Chromatographic materials | WATERS TECHNOLOGIES CORPORATION (US) | 2019-04-23 | — | — | US | disclosed |
| US-20180326399-A1 | CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORPORATION | 2018-11-15 | — | — | US | disclosed |
| US-20160184736-A1 | CHROMATOGRAPHIC COLUMNS AND SEPARATION DEVICES COMPRISING A SUPERFICIALLY POROUS MATERIAL; AND USE THEREOF FOR SUPERCRITICAL FLUID CHROMATOGRAPHY AND OTHER CHROMATOGRAPHY | WATERS TECHNOLOGIES CORPORATION (US) | 2016-06-30 | — | — | US | disclosed |
| WO-2015140566-A1 | PYRAZOLO-PYRIMIDINES AS INHIBITORS OF BTK | REDX PHARMA PLC (GB) | 2015-09-24 | — | — | WO | disclosed |
| US-7897609-B2 | Aryl substituted imidazonaphthyridines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-03-01 | — | — | US | disclosed |
| US-20070219228-A1 | Aryl substituted imidazonaphthyridines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611617-B2 | Chromatographic columns and separation devices comprising a superficially porous material; and use thereof for supercritical fluid chromatography and other chromatography | F11, F12, F2 | F11 1/4885ABAT 4788/4885LOXL2 1442/4885 |
| US-20180326399-A1 | CHROMATOGRAPHIC MATERIALS | HAX1, CXCR1, YBX1 | F11 6/4885ABAT 4406/4885LOXL2 2586/4885 |
| US-20230173406-A1 | CHROMATOGRAPHIC COLUMNS AND SEPARATION DEVICES COMPRISING A SUPERFICIALLY POROUS MATERIAL; AND USE THEREOF FOR SUPERCRITICAL FLUID CHROMATOGRAPHY AND OTHER CHROMATOGRAPHY | SPECC1L, CCL5, CCR5 | F11 680/4885ABAT 4790/4885LOXL2 2920/4885 |
| US-20240293799-A1 | CHROMATOGRAPHIC MATERIALS | HAX1, CXCR1, YBX1 | F11 6/4885ABAT 4406/4885LOXL2 2586/4885 |
| US-20070219228-A1 | Aryl substituted imidazonaphthyridines | IL2, IRF3, EIF2AK2 | F11 4805/4885ABAT 174/4885LOXL2 3916/4885 |
| US-20230312577-A1 | DUAL KINASE-BROMODOMAIN INHIBITORS | MAP2K2, BRPF3, BRDT | F11 4155/4885ABAT 3540/4885LOXL2 1750/4885 |
| US-20160184736-A1 | CHROMATOGRAPHIC COLUMNS AND SEPARATION DEVICES COMPRISING A SUPERFICIALLY POROUS MATERIAL; AND USE THEREOF FOR SUPERCRITICAL FLUID CHROMATOGRAPHY AND OTHER CHROMATOGRAPHY | SPECC1L, CCL5, CCR5 | F11 680/4885ABAT 4790/4885LOXL2 2920/4885 |
| US-11577179-B2 | Chromatographic columns and separation devices comprising a superficially porous material; and use thereof for supercritical fluid chromatography and other chromatography | SEPTIN9, PORCN, SPECC1L | F11 3232/4885ABAT 4596/4885LOXL2 2884/4885 |
| US-20210331138-A1 | CHROMATOGRAPHIC MATERIALS | HAX1, CXCR1, YBX1 | F11 6/4885ABAT 4406/4885LOXL2 2586/4885 |
| US-11992824-B2 | Chromatographic materials | HAX1, CXCR1, YBX1 | F11 6/4885ABAT 4406/4885LOXL2 2586/4885 |
| US-10265679-B2 | Chromatographic materials | HAX1, CXCR1, YBX1 | F11 6/4885ABAT 4406/4885LOXL2 2586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.